Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Shelley Chu acquired 11,111 shares of Odyssey Therapeutics stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $18.00 per share, for a total transaction of $199,998.00. Following the transaction, the director directly owned 11,111 shares in the company, valued at $199,998. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Odyssey Therapeutics Price Performance
Shares of ODTX stock opened at $17.94 on Thursday. Odyssey Therapeutics, Inc. has a twelve month low of $15.35 and a twelve month high of $20.30.
Further Reading
- Five stocks we like better than Odyssey Therapeutics
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
